119 related articles for article (PubMed ID: 32822084)
1. Histopathological imaging-based cancer heterogeneity analysis via penalized fusion with model averaging.
He B; Zhong T; Huang J; Liu Y; Zhang Q; Ma S
Biometrics; 2021 Dec; 77(4):1397-1408. PubMed ID: 32822084
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical cancer heterogeneity analysis based on histopathological imaging features.
Ren M; Zhang Q; Zhang S; Zhong T; Huang J; Ma S
Biometrics; 2022 Dec; 78(4):1579-1591. PubMed ID: 34390584
[TBL] [Abstract][Full Text] [Related]
3. HETEROGENEITY ANALYSIS VIA INTEGRATING MULTI-SOURCES HIGH-DIMENSIONAL DATA WITH APPLICATIONS TO CANCER STUDIES.
Zhong T; Zhang Q; Huang J; Wu M; Ma S
Stat Sin; 2023 Apr; 33(2):729-758. PubMed ID: 38037567
[TBL] [Abstract][Full Text] [Related]
4. Bayesian finite mixture of regression analysis for cancer based on histopathological imaging-environment interactions.
Im Y; Huang Y; Tan A; Ma S
Biostatistics; 2023 Apr; 24(2):425-442. PubMed ID: 37057611
[TBL] [Abstract][Full Text] [Related]
5. Gaussian graphical model-based heterogeneity analysis via penalized fusion.
Ren M; Zhang S; Zhang Q; Ma S
Biometrics; 2022 Jun; 78(2):524-535. PubMed ID: 33501648
[TBL] [Abstract][Full Text] [Related]
6. Bayesian hierarchical finite mixture of regression for histopathological imaging-based cancer data analysis.
Im Y; Huang Y; Huang J; Ma S
Stat Med; 2022 Mar; 41(6):1009-1022. PubMed ID: 35028949
[TBL] [Abstract][Full Text] [Related]
7. Robust analysis of cancer heterogeneity for high-dimensional data.
Cheng C; Feng X; Li X; Wu M
Stat Med; 2022 Nov; 41(27):5448-5462. PubMed ID: 36117143
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-guided heterogeneity analysis of genetic regulations via multivariate sparse fusion.
Zhang S; Hu X; Luo Z; Jiang Y; Sun Y; Ma S
Stat Med; 2021 Jul; 40(17):3915-3936. PubMed ID: 33906263
[TBL] [Abstract][Full Text] [Related]
9. Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer.
Zhong T; Wu M; Ma S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871256
[TBL] [Abstract][Full Text] [Related]
10. Analyzing large datasets with bootstrap penalization.
Fang K; Ma S
Biom J; 2017 Mar; 59(2):358-376. PubMed ID: 27870109
[TBL] [Abstract][Full Text] [Related]
11. Information-incorporated sparse hierarchical cancer heterogeneity analysis.
Han W; Zhang S; Ma S; Ren M
Stat Med; 2024 May; 43(11):2280-2297. PubMed ID: 38553996
[TBL] [Abstract][Full Text] [Related]
12. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
13. Building trans-omics evidence: using imaging and 'omics' to characterize cancer profiles.
Srivastava A; Kulkarni C; Mallick P; Huang K; Machiraju R
Pac Symp Biocomput; 2018; 23():377-387. PubMed ID: 29218898
[TBL] [Abstract][Full Text] [Related]
14. Clustering multilayer omics data using MuNCut.
Teran Hidalgo SJ; Ma S
BMC Genomics; 2018 Mar; 19(1):198. PubMed ID: 29703159
[TBL] [Abstract][Full Text] [Related]
15. Gene-environment interaction identification via penalized robust divergence.
Ren M; Zhang S; Ma S; Zhang Q
Biom J; 2022 Mar; 64(3):461-480. PubMed ID: 34725857
[TBL] [Abstract][Full Text] [Related]
16. Identifying gene-gene interactions using penalized tensor regression.
Wu M; Huang J; Ma S
Stat Med; 2018 Feb; 37(4):598-610. PubMed ID: 29034516
[TBL] [Abstract][Full Text] [Related]
17. Analyzing Association Mapping in Pedigree-Based GWAS Using a Penalized Multitrait Mixed Model.
Liu J; Yang C; Shi X; Li C; Huang J; Zhao H; Ma S
Genet Epidemiol; 2016 Jul; 40(5):382-93. PubMed ID: 27247027
[TBL] [Abstract][Full Text] [Related]
18. Sparse regularized discriminant analysis with application to microarrays.
Li R; Wu B
Comput Biol Chem; 2012 Aug; 39():14-9. PubMed ID: 22820089
[TBL] [Abstract][Full Text] [Related]
19. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
[TBL] [Abstract][Full Text] [Related]
20. Histopathological Imaging⁻Environment Interactions in Cancer Modeling.
Xu Y; Zhong T; Wu M; Ma S
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31022926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
